Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board of Directors has unanimously voted on and approved the appointment of Aaron J. Kowalski, Ph.D., to serve as its new President and CEO, leading Breakthrough T1D’s race to cure type 1 diabetes and to improve […]
Breakthrough T1D Nurtures the Young Adult Community by Hosting Networking Conference and Helping Secure Key Internships
More than 120 Young Adults joined Breakthrough T1D for a weekend of networking, learning and connecting at the Breakthrough T1D Young Adult Conference held in Dallas, Texas on March 30 and 31. Find the photos of this electrifying conference here. The conference experience was enriched by speakers who inspired our participants by talking about living […]
Breakthrough T1D Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications
Two of the world’s most respected and trusted health publications have tapped Breakthrough T1D to serve as an expert voice on their advisory panels. Breakthrough T1D IBOD Vice-Chair Jeff Plumer joins the editorial advisory board of Diabetes Self-Management, an award-winning magazine with more than 7 million readers and has claimed nearly 400 awards of excellence […]
2019 National Volunteer Week
This National Volunteer Week, April 7-13, 2019, Breakthrough T1D celebrates the passion and dedication of our inspiring volunteers! Breakthrough T1D was founded by families and volunteers who wanted to create a world without type 1 diabetes (T1D) and ever since, volunteers have been at the core of everything we do. From the International Board of […]
Testimony of Dr. Aaron Kowalski, Chief Mission Officer, Breakthrough T1D House Energy & Commerce Committee Oversight And Investigations Subcommittee
‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone, Ranking Member Walden and Members of the Subcommittee — thank you for the spotlight you are placing on the issue of insulin affordability. In 1977, my younger brother Stephen was diagnosed with type 1 diabetes. […]
Insulin pumps, CGMs and more: is T1D Tech right for you?
Hear from six people living with T1D about their #T1DTech, the fears they had before using their various devices, and how these options have changed their life with T1D.
Send a Letter to the Administration to Help Lower Insulin Prices
Earlier this year, the U.S. Department of Health and Human Services (HHS) announced a proposal to lower prescription drug prices and out-of-pocket costs by ending the use of rebates in Federally funded health insurance plans (Medicare and Medicaid). If finalized, the rule will help stop the cycle of price increases for insulin, and will require any discounts […]
European Commission Has Approved Forxiga for Adults with Type 1 Diabetes
It’s official: The European Commission has approved Forxiga® (dapagliflozin and marketed in the United States as Farxiga®) for adults with type 1 diabetes (T1D), when used in conjunction with insulin to improve glycemic control. This is the first oral medicine for T1D in Europe, and blocks SGLT, which is responsible for glucose absorption in the […]
Mini, AP Patch Given FDA Nod for Fast-Track Review
A closed-loop patch insulin pump/CGM system has been granted FDA Breakthrough Device Designation by the FDA. The designation is designed to provide a faster track to FDA approval for devices that are considered to provide novel treatment options. The device was created by EOFlow, a company based in South Korea, and the technology was funded […]
